Pinnacle Food Group

PFAI

Capitalización de mercado USD 57.1 M

rhLF expression from the Company's first-generation yeast strain confirmed in a 5-liter bench-scale fermenter; milestone supports further strain optimization and scale-up evaluation VANCOUVER, BC AND HONG KONG, HK / ACCESS Newswire / October 13, 2026 / Pinnacle Food Group Limited (NASDAQ:PFAI) ("Pinnacle Food" or the "Company"), a technology-driven company operating at the intersection of smart farming and bioengineering, today announced that its wholly owned subsidiary, Pinnacle Food AgTech HK Limited ("PFHK"), has successfully completed the first bench-scale fermentation of the Company's first-generation recombinant human lactoferrin ("rhLF") yeast strain in a 5-liter bench-scale fermenter. Laboratory analyses, including high-performance liquid chromatography (HPLC), sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) and Immuno Blotting, confirmed rhLF expression.

VANCOUVER, BC / ACCESS Newswire / August 3, 2026 / Pinnacle Food Group Limited (NASDAQ:PFAI) (the "Company"), today announced the appointment of Mr. Martin Ngai Lam Cheung as an independent director of the Company, effective August 1, 2026.

VANCOUVER, BC / ACCESS Newswire / July 15, 2026 / Pinnacle Food Group Limited (Nasdaq:PFAI) ("Pinnacle Food" or the "Company"), a technology-driven company operating at the intersection of smart farming and bioengineering, today announced the completion of a key project development milestone and the formal commencement of construction of a commercial-scale microalgae-based astaxanthin production facility for Bei Harvest Ltd. ("Bei Harvest") in British Columbia, Canada.

VANCOUVER, BC, June 5, 2026 /PRNewswire/ -- Pinnacle Food Group Limited (Nasdaq: PFAI) (the "Company"), today announced the dismissal of Wencai Pan as Chief Financial Officer and appointment of Dr. Yunhao Chen as Chief Financial Officer of the Company, both effective June 1, 2026. Dr. Chen has extensive public company finance, accounting, U.S. GAAP, SEC reporting and compliance experience.

VANCOUVER, BC and HONG KONG, April 20, 2026 /PRNewswire/ -- Pinnacle Food Group Limited (Nasdaq: PFAI), a technology-driven company operating at the intersection of smart agriculture and bio-engineering, today announced that its subsidiary, Pinnacle Food AgTech HK Limited (PFHK), has entered into a non-binding memorandum of understanding (MOU) with Open Yeast Collection and Bioboost Synbio Consulting Inc. ("Bioboost"). This MOU establishes a preliminary framework to explore the development of an Open Yeast Platform hub located at the Hong Kong-Shenzhen Innovation and Technology Park, a strategic border-zone development uniquely positioned to leverage the integrated technological and regulatory advantages of both Hong Kong and Mainland China.

VANCOUVER, BC and HONG KONG, April 15, 2026 /PRNewswire/ -- Pinnacle Food Group Limited (Nasdaq: PFAI), a technology-driven company operating at the intersection of smart agriculture and bio-engineering, today announced a significant technical milestone in its precision fermentation R&D pipeline achieved at its laboratory in Hong Kong. The research team created the first generation of a recombinant yeast strain to produce human lactoferrin (rhLF) using a patented methanol-free Pichia fermentation method, accessed through the Company's research collaboration with Bioboost.

VANCOUVER, BC, March 13, 2026 /PRNewswire/ -- Pinnacle Food Group Limited (Nasdaq: PFAI), a technology-driven smart farming and bio-engineering company, providing integrated farming-as-a-service solutions and developing biology-enabled platforms to support efficient and sustainable food systems, today announced the successful conclusion of its virtual "Investor Day 2026 & Non-Deal Roadshow." The event drew robust interest from the investment community, with nearly 100 institutional investors, analysts, and wealth managers attending via Zoom and Tencent Meeting.

VANCOUVER, BC, March 2, 2026 /PRNewswire/ -- Pinnacle Food Group Limited (Nasdaq: PFAI), a technology-driven smart farming and bio-engineering company, providing integrated farming-as-a-service solutions and developing biology-enabled platforms to support efficient and sustainable food systems, today announced that it will host its virtual "Investor Day 2026 & Non-Deal Roadshow" on Monday, March 9, 2026 (U.S. Time) / Tuesday, March 10, 2026 (Asia Time). Event Schedule The virtual event will be accessible across multiple time zones to accommodate the Company's global investor base: New York (EDT): Monday, March 9, 2026, from 8:00 PM to 9:00 PM (GMT-04:00) Vancouver (PDT): Monday, March 9, 2026, from 5:00 PM to 6:00 PM (GMT-07:00) Hong Kong (HKT): Tuesday, March 10, 2026, from 8:00 AM to 9:00 AM (GMT+08:00) Webcast and Dial-in Information Investors, analysts, and media representatives are invited to join the meeting via Zoom or VooV Meeting (Tencent Meeting).

VANCOUVER, BC, Jan. 28, 2026 /PRNewswire/ -- Pinnacle Food Group Limited (Nasdaq: PFAI), a technology-driven smart farming and bio-engineering company, providing integrated farming-as-a-service solutions and developing biology-enabled platforms to support efficient and sustainable food systems, today announced that its wholly owned subsidiary, Pinnacle Food AgTech HK Limited, has entered into a research and technology collaboration agreement with Bioboost Synbio Consulting Inc., a biotechnology consulting company based in Vancouver, Canada. Under the agreement, the parties will collaborate on biotechnology and precision fermentation research applications, including research activities related to recombinant human lactoferrin (rhLF), a naturally occurring protein found in human milk that is recognized for its potential applications in health, nutrition, and functional food development.

VANCOUVER, BC , Nov. 24, 2025 /PRNewswire/ -- Pinnacle Food Group Limited (NASDAQ:PFAI) announced a strategic initiative to establish a bioengineering and testing laboratory. The Company is exploring applied bioengineering initiatives to further expand its smart agriculture innovation platform into bioengineering applications, supporting its future growth.